These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 26397944

  • 21. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P, Camilot M, Palma L, Lauriola S, Gaudino R, Vincenzi M, Antoniazzi F, Teofoli F, Piacentini G.
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [Abstract] [Full Text] [Related]

  • 22. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
    Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M.
    Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
    [Abstract] [Full Text] [Related]

  • 23. Measuring steroids from dried blood spots using tandem mass spectrometry to diagnose congenital adrenal hyperplasia.
    Qasrawi DO, Boyd JM, Sadrzadeh SMH.
    Clin Chim Acta; 2021 Sep; 520():202-207. PubMed ID: 34097883
    [Abstract] [Full Text] [Related]

  • 24. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J, Barat P, Fagour L, Corcuff JB.
    Clin Chim Acta; 2012 Aug 16; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract] [Full Text] [Related]

  • 25. Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD, Lee CC.
    J Clin Lab Anal; 2002 Aug 16; 16(1):20-5. PubMed ID: 11835526
    [Abstract] [Full Text] [Related]

  • 26. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
    Güran T, Tezel B, Çakır M, Akıncı A, Orbak Z, Keskin M, Selver Eklioğlu B, Ozon A, Özbek MN, Karagüzel G, Hatipoğlu N, Gürbüz F, Çizmecioğlu FM, Kara C, Şimşek E, Baş F, Aydın M, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):287-294. PubMed ID: 32157855
    [Abstract] [Full Text] [Related]

  • 27. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K, Tsuji-Hosokawa A, Hashimoto A, Konishi K, Ishige N, Yajima H, Sutani A, Nakatani H, Gau M, Takasawa K, Tajima T, Hasegawa T, Morio T, Kashimada K.
    J Clin Endocrinol Metab; 2022 Nov 25; 107(12):3341-3352. PubMed ID: 36071550
    [Abstract] [Full Text] [Related]

  • 28. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry.
    Rossi C, Calton L, Hammond G, Brown HA, Wallace AM, Sacchetta P, Morris M.
    Clin Chim Acta; 2010 Feb 25; 411(3-4):222-8. PubMed ID: 19931522
    [Abstract] [Full Text] [Related]

  • 29. Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population.
    Kim B, Lee MN, Park HD, Kim JW, Chang YS, Park WS, Lee SY.
    Ann Lab Med; 2015 Nov 25; 35(6):578-85. PubMed ID: 26354345
    [Abstract] [Full Text] [Related]

  • 30. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.
    Dhillon K, Ho T, Rich P, Xu D, Lorey F, She J, Bhandal A.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2076-84. PubMed ID: 21803033
    [Abstract] [Full Text] [Related]

  • 31. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug 20; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 32. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 33. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S, Martinerie L, Bouvattier C, Boileau P, Lombès M, Pussard E.
    J Steroid Biochem Mol Biol; 2017 Jan 17; 165(Pt B):202-211. PubMed ID: 27339652
    [Abstract] [Full Text] [Related]

  • 34. Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.
    Han L, Tavakoli NP, Morrissey M, Spink DC, Cao ZT.
    Anal Bioanal Chem; 2019 Jan 17; 411(2):395-402. PubMed ID: 30456606
    [Abstract] [Full Text] [Related]

  • 35. Second-tier test for quantification of underivatized amino acids in dry blood spot for metabolic diseases in newborn screening.
    Wang C, Zhu H, Zhang W, Song F, Liu Z, Liu S.
    Amino Acids; 2013 Feb 17; 44(2):661-71. PubMed ID: 22932943
    [Abstract] [Full Text] [Related]

  • 36. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
    de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL.
    Clin Endocrinol (Oxf); 2021 Jun 17; 94(6):904-912. PubMed ID: 33471388
    [Abstract] [Full Text] [Related]

  • 37. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P, Chalioti MB, Livadara T, Mataragas M, Paliatsiou S, Malamitsi-Puchner A, Moutsatsou P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun 01; 879(19):1565-72. PubMed ID: 21514253
    [Abstract] [Full Text] [Related]

  • 38. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
    Sólyom J, Eckhardt G, Török D.
    Orv Hetil; 2004 Oct 03; 145(40):2051-6. PubMed ID: 15559532
    [Abstract] [Full Text] [Related]

  • 39. Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia.
    Grecsó N, Zádori A, Szécsi I, Baráth Á, Galla Z, Bereczki C, Monostori P.
    PLoS One; 2020 Oct 03; 15(5):e0233724. PubMed ID: 32470014
    [Abstract] [Full Text] [Related]

  • 40. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR, Heather NL, Webster D, Albert BB, Hofman PL.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):e3390-e3399. PubMed ID: 34058748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.